Organon (OGN) Asset Writedowns and Impairment (2021 - 2025)
Organon's Asset Writedowns and Impairment was $301 million in Q4 2025.
Powered by 
Analysis
Organon (OGN) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends
- Asset Writedowns and Impairment shows a four-year compound annual growth rate of 156.1% (FY2021 to FY2025).
- In earlier years, Asset Writedowns and Impairment was $9 million in FY2022 (+28.6%) and $7 million in FY2021.
- The Q4 2025 figure marks the lowest quarterly Asset Writedowns and Impairment since Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Organon | 3.60 Bn | 109.00 Mn | 847.00 Mn |
API Access
Organon Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=OGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "OGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=OGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();